TransCorp Spine Names Christopher Welch President and Chief Executive Officer

TransCorp Spine Names Christopher Welch President and Chief Executive Officer

Share this story with your network

Ada, MI, May 29, 2012 –(PR.com)– TransCorp Spine, Inc., a privately-held medical device company focused on developing minimally-invasive, tissue-saving products and procedures, today named Christopher Welch President and Chief Executive Officer.

Mr. Welch brings a wealth of executive and industry experience to TransCorp Spine with over 25 years in the healthcare and medical device industries. Mr. Welch also brings his creative and strategic thinking along with his keen instinctional ability to select driven individuals and develop strategic organizations that are focused on achieving growth and expansion through innovation.

“TransCorp Spine represents a well-rounded opportunity to adapt the continuum of care for cervical spine patients,” stated Mr. Welch. “I am excited to lead TransCorp Spine through the successful commercialization of our current products and development of our pipeline of new products and procedures.”

Mr. Welch has held several management positions of increasing responsibility within the healthcare industry, including Baxter, Johnson & Johnson, I-Flow and Kimberly Clark, generating triple-digit sales growth and multimillion dollar revenue streams. Most notably, Mr. Welch was General Manager and Vice President of Sales at I-Flow, where he architected a sales transformation that resulted in the I-Flow acquisition made by Kimberly Clark.

“We are pleased to have Chris join the TransCorp Spine team as our President and Chief Executive Officer,” commented Mike DeVries, Managing Director, EDF Ventures, an initial investor in TransCorp Spine. Mr. DeVries added, “We are excited about the company’s future potential under Chris’ leadership.”

About TransCorp Spine, Inc.
TransCorp Spine is an innovative, early-stage, medical device company dedicated to developing minimally-invasive, tissue-saving products and procedures for the treatment of cervical spine pathologies. TransCorp Spine products are designed to enable the surgeon to rapidly, safely and effectively decompress the cervical spine without the need to perform a discectomy, fusion or arthroplasty offering patients an early return to life activities. For more information, please visit our website at: http://www.transcorpspine.com.

Contact:
Christine Moley
201-699-9222
christine@transcorpspine.com

Leave a Comment

Your email address will not be published. Required fields are marked *

*